Pictet Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Sell
43,921
-2,395
-5% -$630K 0.01% 641
2026
Q1
$12.4M Sell
46,316
-975
-2% -$264K 0.01% 602
2025
Q4
$11.9M Sell
47,291
-1,406
-3% -$373K 0.01% 643
2025
Q3
$14M Sell
48,697
-2,304
-5% -$617K 0.01% 602
2025
Q2
$13.4M Buy
51,001
+2,544
+5% +$619K 0.01% 600
2025
Q1
$11.3M Sell
48,457
-485
-1% -$118K 0.01% 625
2024
Q4
$11.2M Buy
48,942
+4,988
+11% +$1.14M 0.01% 630
2024
Q3
$9.82M Sell
43,954
-7,066
-14% -$1.55M 0.01% 658
2024
Q2
$10.4M Sell
51,020
-23,730
-32% -$4.83M 0.01% 619
2024
Q1
$16.3M Sell
74,750
-33,173
-31% -$7.31M 0.02% 541
2023
Q4
$24.5M Sell
107,923
-515
-0.5% -$108K 0.03% 429
2023
Q3
$21.8M Buy
+108,438
New +$22.9M 0.03% 437

Other funds holding LH

Pictet Asset Management's LH Position: Q2 2026 in Review

Pictet Asset Management reduced its Labcorp (LH) stake by 5.2% in Q2 2026, selling an estimated $630K and leaving 43,921 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #641.

Pictet Asset Management first reported a position in LH in Q3 2023 and has held it in 12 quarters since. The position peaked at $24.5M in Q4 2023. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Pictet Asset Management held 43,921 shares of Labcorp worth $12.3M as of Q2 2026.
  • Pictet Asset Management sold 2,395 Labcorp shares in Q2 2026, an estimated $630K.
  • Labcorp made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #641 holding.
  • Pictet Asset Management first reported a position in Labcorp in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Labcorp position peaked at $24.5M in Q4 2023.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.